Long-term effect of pneumococcal conjugate vaccines on tympanostomy tube placements

Pediatric Infectious Disease Journal

Volumn 32, Issue 5, 2013, Pages 517-520

  Sarasoja, Ilona ^a   Jokinen, Jukka ^a   Lahdenkari, Mika ^a   Kilpi, Terhi ^a   Palmu, Arto A ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Middle ear ventilation; Otitis media; Pneumococcal vaccines

Indexed keywords

7 VALENT PNEUMOCOCCAL CONJUGATE VACCINE; HEPATITIS B VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CHILD CARE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; INCIDENCE; INFANCY; MAJOR CLINICAL STUDY; MIDDLE EAR SURGERY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TYMPANOSTOMY TUBE; VACCINATION;

EID: 85027936147     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31827c9bcc     Document Type: Article

References (16)

1. Eskola J, Kilpi T, Palmu A, et al.; Finnish Otitis Media Study Group. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-409.
2. Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 1997;99:318-333.
3. Centers for Disease Control and Prevention. Office-related antibiotic prescribing for persons aged < 14 years - United States, 1993-1994 to 2007-2008. MMWR Morb Mortal Wkly Rep. 2011;34:1153-1156.
4. Owings MF, Kozak LJ. Ambulatory and impatient procedures in the United States, 1996. Vital Health Stat 13. 1998;139:1-119.
5. Haapkylä J, Karevold G, Kvaerner KJ, et al. Trends in otitis media surgery: a decrease in adenoidectomy Int J Pediatr Otorhinolaryngol. 2008;72: 1207-1213.
6. Palmu AA, Verho J, Jokinen J, et al. The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children. Pediatr Infect Dis J. 2004;23:732-738.
7. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19:187-195.
8. Fireman B, Black SB, Shinefield HR, et al. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003;22:10-16.
9. Prymula R, Peeters P, Chrobok V, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet. 2006;367:740-748.
10. Kilpi T, Ahman H, Jokinen J, et al.; Finnish Otitis Media Study Group. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis. 2003;37:1155-1164.
11. Andersen PK, Gill RD: Cox's regression model for counting processes: A large sample study. Ann Stat. 1982;10:1100-1120.
12. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Ass. 1989;82:1075-1078.
13. Âhman H, Palmu A, Kilpi T, et al.; Finnish Otitis Media (Fin OM) Study Group. Persistence of anti-pneumococcal antibodies 3-4 years after immunization with 7-valent pneumococcal conjugate vaccine PncCRM in infancy. ISPPD-2002, the 3rd International Symposium on Pneumococci and Pneumococcal Diseases. Anchorage, Alaska; 2002.
14. Poehling KA, Szilagyi PG, Grijalva CG, et al. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics. 2007;119:707-715.
15. Jardine A, Menzies RI, Deeks SL, et al. The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia. Pediatr Infect Dis J. 2009;28:761-765.
16. Desai SN, Kellner JD, Drummond D. Population-based, age-specific myringotomy with tympanostomy tube insertion rates in Calgary, Canada. Pediatr Infect Dis J. 2002;21:348-350.